Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Hair loss greatly affects women's mental health and appearance satisfaction.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

WAA-QOL measures impact of hair loss on women's well-being.

Over 40% of women have unwanted facial hair, which can affect their self-image, and should be managed with personalized treatment and support.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Timely diagnosis and active treatment improve outcomes for massive pulmonary embolism.

Covid-19 can cause hair loss due to immune and psychological factors.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

Hair loss affects 20% of people, more in men and those over 35, and is often associated with a sensitive scalp.

A nonchemical lotion was found effective in killing head lice and their eggs in most people, indicating it could be useful for managing head lice.

Hair loss linked to prostate enlargement; stress and family history important factors.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.